CEO's presentation to the 2020 AGM
CEO Dr Ken Taylor's presentation to the 2020 AGM
Results of the AGM
In accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act, we advise details of the resolutions and the proxies received in respect of each resolution, which are set out in the attached proxy summary.
September quarter Appendix 4C
LCT ended the quarter with a cash balance of $2,524,461 compared to $2,964,873 in the previous quarter.
Net operating cash flow in the quarter was $(440,109) compared to $(841,919) in the previous quarter. Receipts from grants and tax incentives were $79,153 (previous quarter $40,873).
Annual General Meeting
Living Cell Technologies Limited will hold its Annual General Meeting (“Meeting”) on Thursday, 19 November 2020 at 2:00pm (AEDT).
Due to the coronavirus pandemic and related issues, the Meeting will be held virtually via a live Zoom teleconference, supported by the Company’s Share Registrar, Computershare.
How to jo...